Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy

Haruyuki Kawai, Katsuyuki Kiura, Masahiro Tabata, Tadashi Yoshino, Ichiro Takata, Akio Hiraki, Kenichi Chikamori, Hiroshi Ueoka, Mitsune Tanimoto, Mine Harada

Research output: Contribution to journalArticlepeer-review

44 Citations (Scopus)


We established several in vitro drug-resistant cell lines after continuous, long-term exposure of each drug to elucidate mechanisms of drug resistance. Whether drug resistance in these in vitro resistant cell lines reflects clinical drug resistance still remains unanswered. In this study, a pair of lung cancer cell lines was established from one patient with squamous cell carcinoma of the lung, with one line being established before and one line after combination chemotherapy (cisplatin/ifosfamide/vindesine). Combination chemotherapy selected resistant EBC-2/R cells, which showed cross-resistance to 4-hydroxyifosfamide (3.2-fold), cisplatin (2.3-fold), and methotrexate (3.7-fold) and collateral sensitivity to vindesine (0.77-fold) compared with parent EBC-2 cells. EBC-2/R cells showed decrease in intracellular accumulation of cisplatin, increase in intracellular concentration of glutathione (GSH), and overexpression of multidrug resistance-associated protein (MRP) 3 when compared with EBC-2 cells. A single cycle of chemotherapy was not sufficient to select other mechanisms of drug resistance, such as multidrug resistance-1/P-glycoprotein, MRPs 1, 2, 4, and 5, lung resistance-related protein, metallothionein IIa, glutathione S-transferase π, γ-glutamylcysteine synthetase (light and heavy chain), and excision repair cross complementing 1. Sequentially we established two cell lines, which cell lines showed the differences of the cisplatin resistance, expression level of MRP3, intracellular GSH level and intracellular accumulation of cisplatin. A pair of cell lines will be useful to elucidate resistant mechanisms of cisplatin in heterogeneous lung cancer cells.

Original languageEnglish
Pages (from-to)305-314
Number of pages10
JournalLung Cancer
Issue number3
Publication statusPublished - 2002


  • Accumulation
  • Cisplatin
  • Glutathione
  • In vivo
  • MRP3
  • Methotrexate
  • Non-small-cell lung cancer

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research


Dive into the research topics of 'Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy'. Together they form a unique fingerprint.

Cite this